Inventor
PULÉ MARTIN
GB69 patents
⚠️ This page may combine multiple inventors who share the name “PULÉ MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AUTOLUS LTD
36 patentsUS11091532B2Aug 17, 2021
T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor
AUTOLUS LTD8 citations84
US11034750B2Jun 15, 2021
Chimeric antigen receptor (CAR) comprising a CD19-binding domain
AUTOLUS LTD8 citations84
US10981970B2Apr 20, 2021
Chimeric antigen receptor (CAR) comprising a CD22-binding domain
AUTOLUS LTD4 citations84
US10800855B2Oct 13, 2020
Chimeric cytokine receptors and encoding nucleic acids
AUTOLUS LTD4 citations83
US10800854B2Oct 13, 2020
Chimeric cytokine receptors and encoding nucleic acids
AUTOLUS LTD6 citations83
US10954530B2Mar 23, 2021
Retroviral and lentiviral vectors
AUTOLUS LTD5 citations82
US12187769B2Jan 7, 2025
Cell
AUTOLUS LTD2 citations74
US11058722B2Jul 13, 2021
Chimeric antigen receptor comprising a cartilage-oligomeric matrix protein (comp) coiled-coil spacer domain
AUTOLUS LTD4 citations73
US11851672B2Dec 26, 2023
CAR T-cells comprising transcriptional circuits
AUTOLUS LTD3 citations72
US11479613B2Oct 25, 2022
Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins
AUTOLUS LTD1 citations72
US11365262B2Jun 21, 2022
Cell
AUTOLUS LTD4 citations72
US12049510B2Jul 30, 2024
Chimeric antigen receptor
AUTOLUS LTD2 citations71
US11590170B2Feb 28, 2023
Chimeric antigen receptor
AUTOLUS LTD3 citations71
US11180553B2Nov 23, 2021
Chimeric antigen receptor
AUTOLUS LTD4 citations71
US11466070B2Oct 11, 2022
Signalling system
AUTOLUS LTD2 citations69
US10919951B2Feb 16, 2021
Chimeric antigen receptor
AUTOLUS LTD2 citations69
US11103532B2Aug 31, 2021
Chimeric protein
AUTOLUS LTD2 citations68
US12398194B2Aug 26, 2025
Cell lexpressing two chimeric antigen receptors (CARs) at the cell surface
AUTOLUS LTD0 citations62
US12234295B2Feb 25, 2025
Chimeric transmembrane protein comprising antibody dimerization domains and a type I cytokine receptor endodomain, encoding nucleic acids thereof and methods of use thereof
AUTOLUS LTD0 citations62
US11959084B2Apr 16, 2024
Nucleic acid construct
AUTOLUS LTD1 citations62
US11879016B2Jan 23, 2024
Chimeric antigen receptor
AUTOLUS LTD0 citations62
US11701386B2Jul 18, 2023
Cell
AUTOLUS LTD1 citations62
US11648274B2May 16, 2023
Polypeptide
AUTOLUS LTD0 citations62
US11479614B2Oct 25, 2022
Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptors
AUTOLUS LTD0 citations62
US11242377B2Feb 8, 2022
Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomains
AUTOLUS LTD1 citations62
US10975162B2Apr 13, 2021
Chimeric antigen receptor
AUTOLUS LTD1 citations62
US12454578B2Oct 28, 2025
Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen receptors
AUTOLUS LTD0 citations61
US11345734B2May 31, 2022
Chimeric T cell
AUTOLUS LTD1 citations61
US11982672B2May 14, 2024
Methods
AUTOLUS LTD0 citations60
US11982673B2May 14, 2024
Methods
AUTOLUS LTD0 citations60
US11963981B2Apr 23, 2024
Chimeric antigen receptor
AUTOLUS LTD0 citations60
US11885807B2Jan 30, 2024
Method for depleting malignant T-cells
AUTOLUS LTD0 citations60
US11885806B2Jan 30, 2024
Method for depleting malignant T-cells
AUTOLUS LTD0 citations60
US11814641B2Nov 14, 2023
Retroviral and lentiviral vectors
AUTOLUS LTD0 citations60
US11385233B2Jul 12, 2022
Methods of depleting malignant T-cells
AUTOLUS LTD1 citations60
US12492410B2Dec 9, 2025
Engineered cytolytic immunecell
AUTOLUS LTD0 citations59
UCL BUSINESS PLC
11 patentsUS10172885B2Jan 8, 2019
Cell
UCL BUSINESS PLC24 citations93
US10172886B2Jan 8, 2019
Cell
UCL BUSINESS PLC16 citations93
US10457730B2Oct 29, 2019
Chimeric antigen receptor (CAR) comprising a CD19-binding domain
UCL BUSINESS PLC19 citations90
US10174099B2Jan 8, 2019
Cell
UCL BUSINESS PLC5 citations84
US10098926B2Oct 16, 2018
Cell
UCL BUSINESS PLC10 citations84
US10160794B2Dec 25, 2018
Chimeric antigen receptor
UCL BUSINESS PLC7 citations80
US10098911B2Oct 16, 2018
Chimeric protein
UCL BUSINESS PLC5 citations79
US10654927B2May 19, 2020
Signalling system
UCL BUSINESS PLC4 citations71
US10478457B2Nov 19, 2019
Chimeric protein
UCL BUSINESS PLC2 citations68
US10604570B2Mar 31, 2020
Chimeric antigen receptor signalling system comprising heterodimerization domains
UCL BUSINESS PLC1 citations62
US10286092B2May 14, 2019
Detecting a therapeutic cell
UCL BUSINESS PLC2 citations59
UCL BUSINESS LTD
3 patentsShowing the top 50 of 69 patents by PatentIndex Score.